Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia
Clinical trial NCT02827903 · COMPLETED
Trial details
- NCT number
- NCT02827903
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-15
- Primary completion
- 2017-11-21
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.